TLX Ann: FDA Orphan Drug Designation for Bone Marrow Conditioning - 29th Mar 2022, 11:05am

annb0t

annb0t

Top 20
TLX Ann: FDA Orphan Drug Designation for Bone Marrow Conditioning
Price Sensitive: Y
Date: 29th Mar 2022, 11:05am

>>> Read announcement: Google: TLX Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
TLX Ann: FDA approval of expanded indication of Illuccix in the US - 16th Mar 2023, 10:36am
Replies
0
Views
255
annb0t
annb0t
annb0t
TLX Ann: ProstACT SELECT Study of TLX591 Positive Interim Readout - 19th Oct 2023, 8:18am
Replies
0
Views
121
annb0t
annb0t
annb0t
TLX Ann: Q3 2023 Business Update to Accompany Quarterly Results - 18th Oct 2023, 4:44pm
Replies
0
Views
148
annb0t
annb0t
annb0t
TLX Ann: Activities Report and Appendix 4C - September 2023 Quarter - 18th Oct 2023, 4:42pm
Replies
0
Views
131
annb0t
annb0t
annb0t
TLX Ann: Notification of cessation of securities - TLX - 13th Oct 2023, 8:24am
Replies
0
Views
159
annb0t
annb0t
Top Bottom